Mitochondria are strongly involved in the production of reactive oxygen species, considered as the pathogenic agent of many diseases and of aging. The mitochondrial theory of aging considers somatic mutations of mitochondrial DNA induced by oxygen radicals as the primary cause of energy decline ; experimentally, complex I appears to be mostly affected and to become strongly rate limiting for electron transfer. Mitochondrial bioenergetics is also deranged in human platelets upon aging, as shown by the decreased Pasteur effect (enhancement of lactate production by respiratory chain inhibition). Cells counteract oxidative stress by antioxidants; among lipophilic antioxidants, coenzyme Q is the only one of endogenous biosynthesis. Exogenous coenzyme Q, however, protects cells from oxidative stress by conversion into its reduced antioxidant form by cellular reductases. ß
Introduction
The progressive decline of cell functions with age has been attributed to either a genetic program inborn in all organisms or to the accumulation of stochastic errors in somatic cells leading to a progressive loss of cell functions. Among the stochastic theories, the free radical theory of aging [1] proposed that cells, continuously exposed to reactive oxygen species (ROS), are progressively damaged in their most vital macromolecules. The involvement of mitochondria both as producers and as targets of ROS has been the basis for the mitochondrial theory of aging [2] ; this theory postulates that random mtDNA alterations in somatic cells are responsible for the energetic decline accompanying senescence. It was proposed that accumulation of somatic mutations of mtDNA, induced by exposure to ROS, leads to errors in the mtDNA-encoded polypeptides; these errors are stochastic and randomly transmitted during mitochondrial division and cell division. Such alterations, which a¡ect exclusively the four mitochondrial complexes involved in energy conservation, would result in defective electron transfer and oxidative phosphorylation. Respiratory chain defects may further increase ROS production, thus establishing a vicious circle [3] since any damage to the respiratory chain may enhance ROS production. It is plausible that an acute stress would trigger a mechanism inducing cell death, whereas a milder stress may slowly induce impairment of cell function, as in aging [4] . The notion of a vicious circle of oxidation and mtDNA damage is very controversial, and strongly negated by some authors [5] ; some aspects related to this concept can, however, be proved by demonstrating that ROS production and its e¡ects increase in aging.
The inverse relation of both ROS production and metabolic rate with normal life span of di¡erent animal species [6] bears out the idea that mitochondria, as the sites of oxygen consumption, must be deeply involved in the aging process. Moreover, it was indeed shown that hydrogen peroxide generation increases with age. In isolated rat hepatocytes we have shown that hydrogen peroxide, but not superoxide, production is higher and the e¡ect of an oxidative stress induced by adriamycin is stronger in cells isolated from old rats than from young animals [7] . The observed imbalance between superoxide and hydrogen peroxide may well contribute to enhance the oxidative stress by producing the hydroxyl radical by way of the Fenton reaction [8] . The depolarization of the mitochondria induced by adriamycin in cells from both young and old animals is probably due to opening of the mitochondrial permeability transition pore (cf. [9] ).
Increased production of ROS in aging is also inferred from the increase of oxidized cellular components with age (cf. [4] ). Among the damaged molecules, mtDNA is most important for the mitochondrial theory. The search for point mutations in mtDNA in aging has led to controversial results [10] , but large deletions have been consistently found in aged individuals [11] . Considering the total number of deletions, it was suggested that they can account for such an amount to overcome the threshold required for decreasing the respiratory chain activity. Progressive accumulation of somatic mtDNA rearrangements, formation of mini-circles and progressive cell death by apoptosis accompany aging [12] . Recently, high copy mutations at the D-loop control region for replication and transcription of mtDNA have been described in ¢broblasts from normal old but not young individuals [13] .
The ¢nding of extensive deletions in aging and the notion that oxidative stress can induce deletions [12, 14] are no proof per se that oxidative stress is involved; in fact mtDNA deletions can arise from altered nuclear-mitochondrial interactions [15] .
The cytoplasmic hybrid or`cybrid' transfer technique is now a standard assay for determining whether cellular defects associated with mitochondrial disease are due to mtDNA mutations. The observation that oxidative phosphorylation defects in cultured cells from aged donors could be reversed by fusion of the enucleated cytoplasmic fragments from the old donor cells to immortalized recipient cells [16] suggested that a nuclear mutation might be responsible for the mitochondrial de¢cit; although a subsequent study demonstrated formation of respiratory-de¢cient clones having decreased mtDNA by fusing mitochondria from ¢broblasts of aged donors to b 0 cells [17] , the intervention of nuclear recessive mutations responsible for decreased mitochondrial translation in aging was documented by demonstrating that nuclear hybrids of mtDNAless HeLa cells and ¢broblasts from old donors, formerly de¢cient in mitochondrial protein synthesis, resumed normal translation activity [18] . Thus a unique role of mtDNA in aging has yet to be established.
The search for age-dependent changes in mitochondrial bioenergetics has produced con£icting results, reporting either signi¢cant changes or no di¡er-ences [4] . There may be several reasons for explaining such con£icting data. First, mtDNA mutations are expected to accumulate and to lead to damage mainly in postmitotic cells [19] , where oxidative metabolism is very elevated; moreover, in such cells, the lesions could be conserved, at di¡erence with mitotic cells where division leads to selection and washing away of de¢cient cells. Mitochondria, when isolated, are obtained from tissues containing both di¡erenti-ated non-dividing cells and relatively non-aging dividing cells; thus small changes in one single population may become undetectable [4] ; furthermore energy-de¢cient cells may undergo elimination by apoptosis [20] ; the continuous cell loss when mitochondria become de¢cient would prevent observing important energetic changes in the remaining population.
The best demonstration of bioenergetic alteration in mtDNA-encoded proteins has been the histochemical detection of a loss of cytochrome c oxidase activity (but not of succinate dehydrogenase) in muscle mitochondria from old individuals [21] ; the mosaic distribution of the cytochrome oxidase-de¢cient ¢-bers agrees with the stochastic distribution of mitochondrial damage expected from the mitochondrial theory [2] .
Studies on mitochondria from di¡erent rat tissues
If the energetic impairment derives from a stochastic damage to the mitochondrial genes, then it is important to select the mitochondrial activity that is more likely to be a¡ected. Since seven out of the 13 polypeptides encoded by mtDNA belong to complex I, it is expected that this enzyme should be affected most by aging [22] . The membrane part of the enzyme that carries the binding site of the electron acceptor, coenzyme Q (CoQ), and of several inhibitors, such as rotenone, is composed of the ND subunits which also seem to contribute to the protontranslocation machinery of complex I [23] .
Complex I activity is investigated using low molecular weight quinones [24] , which are homologues or analogues of the natural acceptor, a long isoprenoid chain ubiquinone. Since problems exist in the correct evaluation of complex I activity with the arti¢cial acceptors, we have preferred, when possible, to use the pool equation [25] to calculate complex I activity in liver and heart of aged rats; the experimental rates of NADH-CoQ reductase activity were underestimated, whereas the rates calculated from the pool equation showed clear decreases of activity in the aged animals [25] .
In non-synaptic mitochondrial particles from rat brain cortex [26] , we found that the aerobic NADH oxidation is signi¢cantly decreased in old rats, suggesting a complex I defect; in addition to the decrease of NADH oxidation rate, we also found a decrease of its rotenone sensitivity, evidenced as an increase of the I 50 , the inhibitor concentration eliciting 50% inhibition of activity. Since rotenone, as well as most complex I inhibitors, bind hydrophobic ND subunits [23] , this ¢nding would be in line with the mitochondrial theory. No major changes were found in synaptic mitochondria from brain cortex, an unexpected di¡erence whose explanation may be that they have a lower respiration rate and would therefore be less exposed to ROS attack; another explanation could be that only healthy non-damaged mitochondria migrate by axonal £ow from the cell body to the synapse. Similar changes were obtained in liver mitochondria from 30-month-old rats in comparison with 4-month-old animals.
The relevance of NADH oxidation to complex I activity requires that complex I is rate limiting over the whole respiratory chain, otherwise threshold effects would be present [27] . The metabolic control theory [28] determines the control that various steps in a pathway have over the global £ux of the same pathway; the £ux control coe¤cient is de¢ned as the fractional change in pathway £ux induced by a fractional change in an individual step: values approaching 1 indicate that the step is rate limiting, values approaching zero indicate that the step is not rate limiting. Examination of the rotenone inhibition threshold in NAD-linked respiration (glutamate plus malate) of intact rat liver mitochondria revealed a dramatic decrease in the old animals, indicating that complex I becomes strongly rate limiting with age ( Fig. 1) . Accordingly, NADH-CoQ reductase activity is signi¢cantly decreased in the old animals (see legend of Fig. 1 ).
Age-related changes in human platelets
For investigating aging in humans, blood platelets may represent a unique system, in that they possess mitochondria and are of easy sampling without involving invasive procedures. The rational use of platelets as a bio-marker of mitochondrial lesions [29] rests on the assumption that alterations occurring in senescence and in age-related diseases be present in all cells, and that platelets may signal generalized bioenergetic de¢ciencies.
It is known that platelets rely on glycolysis as well as mitochondrial oxidative phosphorylation for their energy supply [30] : the main function of platelets is their energy-dependent aggregation process, a part of the mechanism of blood clotting, physiologically elicited via exocytosis of their secretory granules.
An alteration of complex I activity in platelet mitochondria in aged individuals is indicated by the increase of I 50 of rotenone inhibition (corrected for complex I content) [31] , similar to that detected in rat brain cortex mitochondria [26] and in platelet mitochondria of patients a¡ected by Leber's hereditary optic neuropathy, a maternally inherited mitochondrial disease with mtDNA mutations of genes encoding hydrophobic ND subunits of complex I [32] . Cross-titrations with di¡erent inhibitors reveal a rather extended rotenone-binding area [23] : the changed rotenone sensitivity concerns three di¡erent forms of Leber's disease, implicating subunits ND1, ND45, and ND6 [32, 33] . Since, as already mentioned, rotenone binds the hydrophobic sector of the enzyme that is involved in proton translocation, the altered inhibitor sensitivity may represent an indication of altered energy conservation. A quantitative determination of glycolytic and mitochondrial ATP can be provided by the Pasteur e¡ect [30] : a decreased mitochondrial function stimulates glycolysis in order to maintain a constant ATP synthesis, and meanwhile pyruvate is reduced to lactate to regenerate oxidized pyridine nucleotides. Since, in the absence of mitochondrial function, the stoichiometric ratio for glucose breakdown in the glycolytic pathway is two ATP and two lactate molecules per glucose, it follows that the lactate production stimulated by inhibition of respiration is equivalent to the correspondingly inhibited production of ATP by mitochondria.
Lactate production by washed platelets is strongly enhanced by antimycin A inhibition of mitochondrial respiration; the v-lactate production in the presence and absence of antimycin A represents the amount of ATP produced via oxidative phosphorylation in physiological conditions, whereas the basal lactate production represents glycolytic ATP [30] . Both the v-lactate and the ratio of oxidative ATP over glycolytic ATP are decreased in aged individuals, although the latter values display much larger variability (Table 1). The decreased extent of stimulated activity in the aged, also evident from Table 1 , would argue for a decreased capacity of the glycolytic system; this, however, can be excluded by the ¢nding that platelet aggregation in the presence of antimycin (and therefore only supported by glycolysis) is not di¡erent in young and old individuals (not shown). A possible reason would be in a diminished ATP utilization in the old.
The site of the mitochondrial bioenergetic lesion observed in platelets is probably respiratory complex I, as shown by the decreased rotenone sensitivity of this enzyme in the aged [31] . We found that thè common' deletion of mtDNA, detected in all postmitotic tissues investigated so far [11] , is not present in platelets [34] ; the mitochondrial theory expects mtDNA to be a¡ected in postmitotic tissues but not in mitotic or short-lived cells [19] , although highly glycolytic cells may be thought to accumulate mitochondrial damage without being negatively selected. The recent observations of a high incidence of age-linked mutations in the D-loop region of dividing ¢broblasts [13] re-launches the mitochondrial theory; however, we cannot exclude other causes of the bioenergetic defects occurring in senescence; a decreased stability in complex I protein structure, leading to decreased rotenone sensitivity and to decreased energy conservation, could be alternatively due to direct damage of the enzymatic proteins or of the lipid environment of the enzyme [4] . To this respect, the reported decrease of cardiolipin content in the aged was accompanied by decreased cytochrome oxidase activity [35] .
Oxidative stress and antioxidant role of coenzyme Q
Cells contain enzymatic and non-enzymatic systems capable to convert ROS into less toxic or non-toxic species. Among antioxidants, a special position is held by coenzyme Q, the only lipid-soluble antioxidant which is normally synthesized by the organism [36] . The biosynthesis of CoQ is particularly complex: the benzoquinone ring is synthesized from the essential amino acid phenylalanine up to 4-hydroxybenzoate, whereas the isoprenoid chain is formed by a pathway common to that of cholesterol and dolichol biosynthesis [37] . CoQ biosynthesis requires the dietary intake of several vitamin cofactors; it is therefore conceivable that one or more such factors may become limiting [36] , thus slowing down ubiquinone biosynthesis and inducing a de¢-ciency state.
Besides its bioenergetic role, as a component of the mitochondrial respiratory chain, CoQ is also a component of extramitochondrial redox chains, whose function, among others, would be to remove excess reducing power formed by glycolysis when mitochondrial respiration is decreased [38] . The role of CoQ in relation with ROS is intriguing: in spite of the CoQ intermediates in the function of complexes I and III being considered as the source of one-electron oxygen reduction [4] , ubiquinone in its reduced form is a powerful antioxidant. As an antioxidant, the reduced form of CoQ is exploited either directly upon superoxide or indirectly on lipid radicals [39] ; ubiquinol can also act together with vitamin E (K-tocopherol) by regenerating the active form from the tocopheroxyl radical [40] . The antioxidant action of ubiquinol yields the ubisemiquinone radical; this species is converted back to its antioxidant form by re-reduction, which occurs through the electron transfer chain in mitochondria, and is operated by various quinone reductases present in di¡erent cell fractions [41, 42] , including the plasma membrane [43] . Ubiquinone may be transformed from a safe electron carrier to a superoxide generator when the ubisemiquinone anion, arising from one-electron oxidation of ubiquinol, becomes accessible to protons [44] ; such a condition may originate from changes in membrane structure.
Studies in perfused rat liver [45] and in isolated rat hepatocytes [41] clearly showed the antioxidant e¡ect of exogenous added CoQ 10 . The anticancer quinone glycoside, adriamycin, induces an oxidative stress by enhancing ROS production in mitochondria and endoplasmic reticulum. In hepatocytes, adriamycin enhances ROS production; concomitantly endogenous CoQ is re-oxidized and the mitochondrial membrane potential falls. Incubation of the cells with exogenous CoQ 10 prevents ROS formation and protects both reduced CoQ and the v8 mit (Fig. 2) . The cytosolic enzyme DT-diaphorase seems to be responsible for reduction of both endogenous and exogenous CoQ, as shown by the e¡ect of dicoumarol, an inhibitor of DT-diaphorase, preventing the protective action of exogenous CoQ addition [41] . We have found an increase of the plasma membrane oxidoreductase system, including an increase of DT-diaphorase (its dicoumarol-sensitive portion) in insulin-dependent diabetic patients whose mitochondrial function was also found to be a¡ected [46] ; such an increase may be related, besides to the necessity of releasing the excess of cytosolic reducing power [20] , to a higher requirement for the reduced antioxidant form of CoQ, due to the oxidative stress occurring in diabetes. If aging is the result of prolonged oxidative stress, an adequate antioxidant supply might contrast the process. The content of vitamin antioxidants depends on dietary intake, and may be subjected to decreases due to de¢cient intestinal absorption defects and bad dietary habits of the aged. CoQ, being synthesized, is a special case. Some studies have shown a CoQ decrease with age (discussed in [25] ); however, this is not true for brain, where high levels are maintained throughout aging [47, 48] in accordance with the steady level of nonaprenyl-4-hydroxybenzoate transferase [48] . Nevertheless, even if the levels of CoQ and other antioxidants do not dramatically fall with aging, we must consider that the antioxidant defenses should actually strongly increase to cope with the enhanced oxidative stress, as was indeed found under conditions of surgical stress [49] .
Senescence is associated to increased incidence of degenerative diseases, such as Parkinson's and Alzheimer's diseases and age-linked macular degeneration; these diseases often have a strong genetic component, which is, however, associated to exogenous factors, among which oxidative stress and mitochondrial involvement may be major triggering factors (cf. [50] ). A decrease of CoQ 10 and of antioxidant defenses in plasma was found in our laboratory in patients a¡ected by age-related macular degeneration of the retina [51] . Fig. 2 . Protection by exogenous CoQ 10 of isolated rat hepatocytes from oxidative stress induced by 50 WM adriamycin. Experimental conditions were as in [40] . The mitochondrial membrane potential v8 mit was measured by £ow cytometry using rhodamine 123 as probe; data are expressed in £uorescence arbitrary units. Hydrogen peroxide was assayed by £ow cytometry and dichloro£uorescein diacetate as probe; data are expressed as pmol/10 6 cells using a calibration curve. Reduced and oxidized CoQ homologues were assayed by HPLC. Total CoQ 9 concentration in controls was 727.6 pmol/10 6 cells and did not vary after adriamycin and CoQ 10 addition; total CoQ 10 was 125.2 pmol/10 6 cells in controls and did not vary after adriamycin addition ; after addition of exogenous CoQ 10 , its content rose to 1154.0 pmol/10 6 cells.
The proposal of an antioxidant therapy, as an attempt to reduce or retard the damaging e¡ect of ROS in aging and age-related degenerative diseases, is strongly supported by the excellent results obtained in Alzheimer disease and Huntington disease [52] . The use of CoQ as a dietary supplement requires its distribution to de¢cient tissues. Dietary CoQ is quickly taken up into blood, where it is mainly transported by LDL [53] , and is rapidly incorporated in liver and reticulo-endothelial cells. The uptake of CoQ 10 by other tissues has not been shown in nutritional experiments in the rat [54] , although there are indirect observations suggesting its incorporation in tissues when the endogenous levels are lowered [55] . In spite of the lack of uptake of dietary CoQ 10 by rat heart mitochondria, the exogenous quinone was found in our studies to strongly protect mitochondria from oxidative changes [56] .
